MEDP — Medpace Holdings, Inc.

—
Nasdaq · Health Care · Life Sciences Tools & Services · CIK 1668397 ·
Last close
$653.09
Market Cap
$18.27B
52W High
$693.97
52W Low
$373.00
ADV30
282,815
Next earnings
2026-10-21

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 716,000,000 223,885,000 165,540,000 137,460,000 2,302,595,000 705,315,000 1,717,656,000
Jun 2026 707,331,000 201,637,000 146,824,000 121,362,000 2,057,181,000 502,688,000 1,623,320,000
Mar 2026 706,604,000 196,326,000 141,503,000 123,870,000 2,129,613,000 652,681,000 1,531,299,000
Dec 2025 708,450,000 205,316,000 153,269,000 135,133,000 1,975,472,000 497,049,000 1,516,401,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$752,660,000
Investing CF
$-45,766,000
Financing CF
$-249,528,000
CapEx
$-45,974,000
Dividends Paid
—
Buybacks
$-299,338,000
EPS Diluted TTM
$17.06
As of
2026-10-25

Balance + Analyst (yfinance extras)

Retained Earnings
$-511,368,000
Inventory
—
Receivables
$441,797,000
ST Investments
—
EBIT TTM
$583,404,000
Pretax Income TTM
$598,923,000
Interest Exp TTM
—
Analysts
13

Yahoo Snapshot (yfinance, live)

Total Revenue
$2,838,384,896
EBITDA
$634,462,976
Free Cash Flow
$497,776,000
Enterprise Value
$18,184,654,848
Total Cash
$705,315,008
Total Debt
$171,458,000
Shares Out
27,971,686
Trailing EPS
$18.01
Book Value
$20.92
ROE
117.9%
ROA
18.7%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 2,530,234,000 534,935,000 451,123,000 1,975,472,000 1,516,401,000 459,071,000 713,223,000
Dec 2024 2,109,054,000 446,870,000 404,386,000 2,100,866,000 1,275,321,000 825,545,000 608,815,000
Dec 2023 1,885,842,000 336,825,000 282,810,000 1,656,828,000 1,097,878,000 558,950,000 433,374,000
Dec 2022 1,459,996,000 278,697,000 245,368,000 1,352,495,000 966,108,000 386,387,000 388,050,000

TTM Snapshot

Revenues TTM
$2,782,288,000
NetIncome TTM
$491,500,000
OpCashFlow TTM
—
Assets (Latest)
$2,057,181,000
Forward EPS
$19.85

Max Pain — expiry 2026-12-18

max pain strike: $570.00 · spot: $646.87 · call oi: 701 · put oi: 2,208

Peers — same industry

TickerNameMarket CapLastDaily %
CRL CHARLES RIVER LABORATORIES INTERNATIONAL, INC. $15.92B $332.16 —
ICLR ICON PLC $15.05B $195.02 —
INCY INCYTE CORP $24.27B $119.09 —
IQV IQVIA HOLDINGS INC. $42.45B $257.60 —
LNTH Lantheus Holdings, Inc. $6.66B $101.80 —

News headlines (Yahoo Finance, 1h cache)

CON or MEDP: Which Is the Better Value Stock Right Now?
2026-11-18 15:40 · Yahoo
Are Options Traders Betting on a Big Move in Medpace Stock?
2026-11-16 12:57 · Yahoo
3 Reasons Why Growth Investors Shouldn't Overlook Medpace (MEDP)
2026-11-11 16:45 · Yahoo
Did Earnings Beat Just Shift Medpace Holdings (MEDP) Investment Narrative?
2026-11-05 08:15 · Yahoo
CON vs. MEDP: Which Stock Is the Better Value Option?
2026-11-02 15:40 · Yahoo
Medpace (MEDP) is a Great Momentum Stock: Should You Buy?
2026-10-30 15:00 · Yahoo
Is Medpace (MEDP) Stock Outpacing Its Medical Peers This Year?
2026-11-13 13:40 · Yahoo
ALC's Q3 Earnings Beat, Revenues Miss, '26 Outlook Narrows, Stock Down
2026-11-11 16:37 · Yahoo
TECH Q1 Earnings & Revenues Beat, Merck KGaA Merger Deal Advances
2026-11-09 12:50 · Yahoo
Mettler-Toledo Stock Up on Q3 Earnings & Revenue Beat, '26 View Up
2026-11-06 13:08 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.